Trevi Therapeutics to Present and Participate in Partnership Meetings at Upcoming 2022 BIO International Convention
/PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™ (nalbuphine...
Source: prnewswire.com